The revised EBM catalog came into force in Germany in January 2023

16

Jan 2023

The reimbursement of services in the public outpatient sector in Germany is regulated in the EBM catalog (Einheitlicher Bewertungsmaßstab), updated once a quarter (four times a year). The adaption timeframe of the EBM catalog for a specific code is around five years but varies depending on the evidence. The latest EBM (German Uniform Evaluation Standard) catalog came into force on January 1, 2023.

The most significant changes concern introducing the EBM codes for several IVD tests and further promoting outpatient (day case) surgical services.

As a part of the previously announced further development of the EBM catalog, since January 1, 2023, additional funding of €60 million is available to promote outpatient (day case) surgical services; so that the reimbursement of the affected procedures is increased by 16% up to 42%. Also, 196 OPS (procedure) codes were included in Annex 2 of the EBM catalog, mainly for neuromodulation, rhythm surgery, as well as arthroscopic interventions, providing the possibility to perform these procedures on an outpatient (day case) basis.

The examples of the new codes in the IVD field introduced in the EBM catalog are provided below:

  • 08315 “Cytological examination of one or more specially stained smears to diagnose hormonal function” with a tariff of €3.10;
  • 19327 “Cytological examination of one or more swabs from the ectocervix and/or from the cervical canal” with a tariff of €20.68 was introduced in the catalog. The code additionally covers further immunocytochemical examinations, using special staining to diagnose the hormonal function as optional services;
  • 19328 “DNA and/or mRNA detection exclusively for high-risk HPV types and genotyping for HPV type 16 and HPV type 18” with a tariff of €21.60;
  • 32810 “Nucleic acid detection of Orthopoxvirus spp. from maculo-/vesiculopapular skin or mucous membrane lesions (findings to be reported within 24 hours of receipt of material in the laboratory)” with a tariff of €19.90.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

27

Jan 2023

On January 09, 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published 2023 tariffs for the “low variability care” (APR-DRG) system. APR-DRG logic for 2023 is not published as of January 27, so no information about its changes or new DRGs is available.

Read more

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

Read more